Scilex Holding (SCLX) Other Non Operating Income (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Other Non Operating Income of -$279000.0 for Q1 2026, down 102.68% year-over-year from $10.4 million in Q1 2025, and down 100.34% on a QoQ basis from $82.1 million in Q4 2025.

Scilex Holding (SCLX) Other Non Operating Income (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Other Non Operating Income for 6 consecutive years, with -$279000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 102.68% year-over-year to -$279000.0; the TTM figure through Mar 2026 stood at $81.7 million (up 222.33% YoY), while the FY2025 annual figure was $21.8 million, up 25.45% from the prior year.
  • Other Non Operating Income came in at -$279000.0 for Q1 2026 at Scilex Holding, down from $82.1 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $82.1 million in Q4 2025, with the low at -$5.3 million in Q1 2023.
  • Average Other Non Operating Income over 5 years is $6.7 million, with a median of -$2000.0 recorded in 2025.
  • Across the five-year window, Other Non Operating Income sank 4047.37% in 2022 and soared 13593.55% in 2023, its largest moves.
  • Year by year, Other Non Operating Income stood at $3.0 million in 2022, then tumbled by 67.71% to $972000.0 in 2023, then jumped by 1444.34% to $15.0 million in 2024, then surged by 447.09% to $82.1 million in 2025, then plunged by 100.34% to -$279000.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$279000.0, $82.1 million, and -$2000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -279,000.00
Dec 31, 2025 82.12 Mn
Sep 30, 2025 -2,000.00
Jun 30, 2025 -99,000.00
Mar 31, 2025 10.40 Mn
Dec 31, 2024 15.01 Mn
Sep 30, 2024 -46,000.00
Jun 30, 2024 -5,000.00
Mar 31, 2024 -457,000.00
Dec 31, 2023 972,000.00
Sep 30, 2023 4.25 Mn
Jun 30, 2023 -82,000.00
Mar 31, 2023 -5.25 Mn
Dec 31, 2022 3.01 Mn
Sep 30, 2022 31,000.00
Jun 30, 2022 -2.70 Mn
Mar 31, 2022 7.50 Mn
Dec 31, 2021 -9.86 Mn
Sep 30, 2021 1.16 Mn
Jun 30, 2021 68,400.00